PNC Financial Services Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-115
| Closed | -$1.51K | – | 4789 |
|
|
2024
Q3 | $1.51K | Hold |
115
| – | – | ﹤0.01% | 4349 |
|
|
2024
Q2 | $1.62K | Sell |
115
-52
| -31% | -$731 | ﹤0.01% | 4311 |
|
|
2024
Q1 | $2.82K | Buy |
+167
| New | +$2.82K | ﹤0.01% | 4123 |
|
|
2022
Q3 | – | Sell |
-500
| Closed | -$1K | – | 4442 |
|
|
2022
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 4313 |
|
|
2022
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 4094 |
|
|
2021
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 4002 |
|
|
2021
Q3 | $5K | Hold |
500
| – | – | ﹤0.01% | 3925 |
|
|
2021
Q2 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 3970 |
|
|
2020
Q3 | – | Sell |
-300
| Closed | -$2K | – | 3919 |
|
|
2020
Q2 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 3750 |
|
|
2017
Q3 | – | Sell |
-10,956
| Closed | -$121K | – | 4134 |
|
|
2017
Q2 | $121K | Buy |
10,956
+10,532
| +2,484% | +$116K | ﹤0.01% | 2411 |
|
|
2017
Q1 | $4K | Hold |
424
| – | – | ﹤0.01% | 3783 |
|
|
2016
Q4 | $4K | Sell |
424
-496,443
| -100% | -$4.68M | ﹤0.01% | 3704 |
|
|
2016
Q3 | $6.16M | Buy |
496,867
+36,657
| +8% | +$455K | 0.01% | 604 |
|
|
2016
Q2 | $4.94M | Buy |
460,210
+87,954
| +24% | +$945K | 0.01% | 646 |
|
|
2016
Q1 | $4.11M | Buy |
+372,256
| New | +$4.11M | ﹤0.01% | 684 |
|
|
2015
Q3 | – | Sell |
-147
| Closed | -$3K | – | 4611 |
|
|
2015
Q2 | $3K | Buy |
+147
| New | +$3K | ﹤0.01% | 4244 |
|
|
2014
Q2 | – | Sell |
-15,000
| Closed | -$201K | – | 3810 |
|
|
2014
Q1 | $201K | Buy |
15,000
+970
| +7% | +$13K | ﹤0.01% | 1893 |
|
|
2013
Q4 | $113K | Buy |
14,030
+6,000
| +75% | +$48.3K | ﹤0.01% | 2121 |
|
|
2013
Q3 | $53K | Buy |
+8,030
| New | +$53K | ﹤0.01% | 2455 |
|